ICML 2019 | Liquid biopsy making strides forward in NHL: detection of ctDNA and mutations

Wyndham Wilson

Wyndham Wilson, MD, PhD, Center for Cancer Research, National Cancer Institute, Bethesda, MD, discusses the exciting field of liquid biopsy in non-Hodgkin lymphoma. He covers its use to detect ctDNA, as well as mutations, and the applications of these measurements. This interview took place at the 15th International Conference on Malignant Lymphoma (ICML), in Lugano, Switzerland.

Share this video